The study of he efficacy of combination enoxaparin and physical therapy for perioperative venous thrombosis (VTE) prevention after laparoscopic colon cancer surgery
- Conditions
- venous thromboembolism (VTE)
- Registration Number
- JPRN-UMIN000033749
- Lead Sponsor
- Hyogo college of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 302
Not provided
1. Patient who is bleeding 2. Patients with complications that may cause bleeding (excluding diseases subject to surgery) 3. Patient who does not retain main organ function (measured within 42 days before registration date by blood test) 4. Patients whose history of hypersensitivity to the test drug components, heparin, heparin derivatives (low molecular weight heparin, etc.) has been confirmed 5. Patients with a history of cerebral hemorrhage 6. Patients who underwent surgery of the central nervous system (brain, spine) or ophthalmic surgery (excluding cataract surgery) within 3 months before the trial registration 7. Patients with contrast medium allergy 8. Patients with a history of heparin-induced thrombocytopenia (HIT) 9. Patients who underwent major orthopedic surgery, abdominal surgery or cardiovascular surgery on the lower extremities within 3 months prior to registration of this study 10. In this study, patients who received the following combination prohibited drug within one week before registration (Heparin, low molecular weight heparin, danaparoid, antithrombin agent, warfarin, thrombolytic agent, antiplatelet drug) 11. Patients requiring heparin substitution during the perioperative period 12. In preoperative examination, patients diagnosed with VTE 13. Patients with a history of arterial thromboembolism (including cerebral infarction and myocardial infarction) 14. Patients with drug dependence or alcoholism 15. Patients who are planning other surgical operations during the study period 16. Patients who are pregnant or have a possibility of pregnancy 17. Patients participating in other clinical trials at the same time as this study (except observational research) 18. Other patients who are judged inappropriate by the examination responsible doctor or the test sharing doctor as the examination subject
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Presence or absence of expression of VTE after colon resection
- Secondary Outcome Measures
Name Time Method 1. Presence or absence of Major bleeding 2. Presence or absence of Minor bleeding 3. Measurement result of anti-PF4 / heparin antibody